Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20491147

Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity : Effects of Docetaxel on Immune Enhancement

Author
GARNETT, Charlie T1 ; SCHLOM, Jeffrey1 ; HODGE, James W1
[1] Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, United States
Source

Clinical cancer research. 2008, Vol 14, Num 11, pp 3536-3544, 9 p ; ref : 40 ref

ISSN
1078-0432
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
American Association for Cancer Research, Philadelphia, PA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Activité biologique Anticancéreux Docétaxel Réponse immune Vaccin recombinant Antimitotique Dérivé du taxane
Keyword (en)
Biological activity Antineoplastic agent Docetaxel Immune response Recombinant vaccine Antimitotic Taxane derivatives
Keyword (es)
Actividad biológica Anticanceroso Docetaxel Respuesta inmune Vacuna recombinante Antimitótico Taxane derivado
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20491147

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web